[en] Epidermal keratinocytes form a structural and immune barrier that is essential for skin homeostasis. However, the mechanisms that regulate epidermal barrier function are incompletely understood. Here we have found that keratinocyte-specific deletion of the gene encoding RAB guanine nucleotide exchange factor 1 (RABGEF1, also known as RABEX-5) severely impairs epidermal barrier function in mice and induces an allergic cutaneous and systemic phenotype. RABGEF1-deficient keratinocytes exhibited aberrant activation of the intrinsic IL-1R/MYD88/NF-kappaB signaling pathway and MYD88-dependent abnormalities in expression of structural proteins that contribute to skin barrier function. Moreover, ablation of MYD88 signaling in RABGEF1-deficient keratinocytes or deletion of Il1r1 restored skin homeostasis and prevented development of skin inflammation. We further demonstrated that epidermal RABGEF1 expression is reduced in skin lesions of humans diagnosed with either atopic dermatitis or allergic contact dermatitis as well as in an inducible mouse model of allergic dermatitis. Our findings reveal a key role for RABGEF1 in dampening keratinocyte-intrinsic MYD88 signaling and sustaining epidermal barrier function in mice, and suggest that dysregulation of RABGEF1 expression may contribute to epidermal barrier dysfunction in allergic skin disorders in mice and humans. Thus, RABGEF1-mediated regulation of IL-1R/MYD88 signaling might represent a potential therapeutic target.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Marichal, Thomas ; Université de Liège > Département des sciences fonctionnelles (DSF) > GIGA-R : Biochimie et biologie moléculaire
Gaudenzio, Nicolas
El Abbas, Sophie ; Université de Liège > Département des sciences fonctionnelles (DSF) > Physiologie
Sibilano, Riccardo
Zurek, Oliwia
Starkl, Philipp
Reber, Laurent L.
Pirottin, Dimitri ; Université de Liège > Département des sciences fonctionnelles (DSF) > Département des sciences fonctionnelles (DSF)
Kim, Jinah
Chambon, Pierre
Roers, Axel
Antoine, Nadine ; Université de Liège > Département de morphologie et pathologie (DMP) > Histologie
Kawakami, Yuko
Kawakami, Toshiaki
Bureau, Fabrice ; Université de Liège > Département des sciences fonctionnelles (DSF) > GIGA-R : Biochimie et biologie moléculaire
Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest. 2012;122(2):440-447.
Kuo IH, Yoshida T, De Benedetto A, Beck LA. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(2):266-278.
Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365(14):1315-1327.
Furuse M, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol. 2002;156(6):1099-1111.
Kirschner N, Brandner JM. Barriers and more: functions of tight junction proteins in the skin. Ann N Y Acad Sci. 2012;1257:158-166.
Miller LS. Toll-like receptors in skin. Adv Dermatol. 2008;24:71-87.
Terhorst D, Kalali BN, Ollert M, Ring J, Mempel M. The role of toll-like receptors in host defenses and their relevance to dermatologic diseases. Am J Clin Dermatol. 2010;11(1):1-10.
O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007;7(5):353-364.
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5):373-384.
Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the 'epim-munome'. Nat Immunol. 2010;11(8):656-665.
Pasparakis M. Regulation of tissue homeo-stasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009;9(11):778-788.
Kondo T, Kawai T, Akira S. Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 2012;33(9):449-458.
Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy. 2014;69(1):3-16.
Holgate ST. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol. 2007;28(6):248-251.
Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol. 2004;4(12):978-988.
Kaplan DH, Igyártó BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol. 2012;12(2):114-124.
Novak N, et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol. 2008;128(6):1430-1435.
Palmer CN, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-446.
Kawasaki H, et al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J Allergy Clin Immunol. 2012;129(6):1538-1546.e6.
Scharschmidt TC, et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol. 2009;124(3):496-506, 506.e1.
Yoo J, et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lympho-poietin transgene specifically in the skin. J Exp Med. 2005;202(4):541-549.
Jariwala SP, Abrams E, Benson A, Fodeman J, Zheng T. The role of thymic stromal lymphopoi-etin in the immunopathogenesis of atopic dermatitis. Clin Exp Allergy. 2011;41(11):1515-1520.
Liu YJ, et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol. 2007;25:193-219.
Abramovits W, Rivas Bejarano JJ, Valdecantos WC. Role of interleukin 1 in atopic dermatitis. Dermatol Clin. 2013;31(3):437-444.
Corsini E, Galli CL. Epidermal cytokines in experimental contact dermatitis. Toxicology. 2000;142(3):203-211.
Oyoshi MK, He R, Kumar L, Yoon J, Geha RS. Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol. 2009;102:135-226.
Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151-160.
Novak N. New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy. 2009;64(2):265-275.
Penengo L, et al. Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin. Cell. 2006;124(6):1183-1195.
Delprato A, Merithew E, Lambright DG. Structure, exchange determinants, and family-wide rab specificity of the tandem helical bundle and Vps9 domains of Rabex-5. Cell. 2004;118(5):607-617.
Tam SY, et al. RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Nat Immunol. 2004;5(8):844-852.
Kalesnikoff J, et al. Roles of RabGEF1/Rabex-5 domains in regulating Fc epsilon RI surface expression and Fc epsilon RI-dependent responses in mast cells. Blood. 2007;109(12):5308-5317.
Kalesnikoff J, et al. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. Proc Natl Acad Sci USA. 2006;103(8):2659-2664.
Tsai M, et al. Thymic stromal lymphopoietin contributes to myeloid hyperplasia and increased immunoglobulins, but not epidermal hyperpla-sia, in RabGEF1-deficient mice. Am J Pathol. 2010;177(5):2411-2420.
Weiss RA, Eichner R, Sun TT. Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48-and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol. 1984;98(4):1397-1406.
Fluhr JW, Feingold KR, Elias PM. Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models. Exp Dermatol. 2006;15(7):483-492.
Warner N, Núñez G. MyD88: a critical adaptor protein in innate immunity signal transduction. J Immunol. 2013;190(1):3-4.
Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 1997;7(6):837-847.
West MA, et al. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science. 2004;305(5687):1153-1157.
West MA, et al. TLR ligand-induced podosome disassembly in dendritic cells is ADAM17 dependent. J Cell Biol. 2008;182(5):993-1005.
Clarke TB, Francella N, Huegel A, Weiser JN. Invasive bacterial pathogens exploit TLR-medi-ated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe. 2011;9(5):404-414.
Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysac-charide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013;182(2):375-387.
Vaezi A, Bauer C, Vasioukhin V, Fuchs E. Actin cable dynamics and Rho/Rock orchestrate a polarized cytoskeletal architecture in the early steps of assembling a stratified epithelium. Dev Cell. 2002;3(3):367-381.
Nusrat A, et al. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc Natl Acad Sci USA. 1995;92(23):10629-10633.
Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL. The microbiome extends to subepidermal compartments of normal skin. Nat Commun. 2013;4:1431.
Zeeuwen PL, Kleerebezem M, Timmerman HM, Schalkwijk J. Microbiome and skin diseases. Curr Opin Allergy Clin Immunol. 2013;13(5):514-520.
Ando T, et al. Mast cells are required for full expres sion of allergen/SEB-induced skin inflammation. J Invest Dermatol. 2013;133(12):2695-2705.
Kawakami Y, Yumoto K, Kawakami T. An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases. Allergol Int. 2007;56(4):403-409.
Ming ME. Book and new media reviews: An atlas of histopathology of skin diseases: An illustrated textbook and reference for clinicians. Arch Dermatol. 2000;136(7):944.
Trautmann A, Akdis M, Bröcker EB, Blaser K, Akdis CA. New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis. Trends Immunol. 2001;22(10):530-532.
Plager DA, et al. Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications. Exp Dermatol. 2007;16(1):28-36.
Olsson M, et al. Increased expression of aquaporin 3 in atopic eczema. Allergy. 2006;61(9):1132-1137.
Gittler JK, et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130(6):1344-1354.
Suárez-Fariñas M, et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. J Allergy Clin Immunol. 2015;135(5):1218-1227.
O'Regan GM, Irvine AD. The role of filaggrin loss-of-function mutations in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2008;8(5):406-410.
De Benedetto A, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127(3):773-86.e1.
Sugawara T, et al. Tight junction dysfunction in the stratum granulosum leads to aberrant stra-tum corneum barrier function in claudin-1-defi-cient mice. J Dermatol Sci. 2013;70(1):12-18.
Yokouchi M, et al. Epidermal tight junction bar rier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum. J Dermatol Sci. 2015;77(1):28-36.
González-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta. 2008;1778(3):729-756.
Gahring LC, Buckley A, Daynes RA. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J Clin Invest. 1985;76(4):1585-1591.
Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM. Interleukin 1 is present in normal human epidermis. J Immunol. 1986;136(9):3317-3323.
Lee S, et al. Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5. Nat Struct Mol Biol. 2006;13(3):264-271.
Mattera R, Tsai YC, Weissman AM, Bonifacino JS. The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. J Biol Chem. 2006;281(10):6874-6883.
Horiuchi H, et al. A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell. 1997;90(6):1149-1159.
Husebye H, et al. Endocytic pathways regulate Tolllike receptor 4 signaling and link innate and adaptive immunity. EMBO J. 2006;25(4):683-692.
Lee EG, et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science. 2000;289(5488):2350-2354.
Lippens S, et al. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeo-stasis. Cell Death Differ. 2011;18(12):1845-1853.
Diatchenko L, et al. Identification of novel mediators of NF-κB through genome-wide survey of monocyte adherence-induced genes. J Leukoc Biol. 2005;78(6):1366-1377.
Lippens S, Hoste E, Vandenabeele P, Agostinis P, Declercq W. Cell death in the skin. Apoptosis. 2009;14(4):549-569.
Pasparakis M, Luedde T, Schmidt-Supprian M. Dissection of the NF-κB signalling cascade in transgenic and knockout mice. Cell Death Differ. 2006;13(5):861-872.
Seitz CS, Freiberg RA, Hinata K, Khavari PA. NF-κB determines localization and features of cell death in epidermis. J Clin Invest. 2000;105(3):253-260.
Rebholz B, et al. Crosstalk between keratinocytes and adaptive immune cells in an IκBα protein-mediated inflammatory disease of the skin. Immunity. 2007;27(2):296-307.
Kobayashi T, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42(4):756-766.
Leung DY, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest. 1993;92(3):1374-1380.
Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974;90(5):525-530.
Nakamura Y, et al. Staphylococcus 5-toxin induces allergic skin disease by activating mast cells. Nature. 2013;503(7476):397-401.
Scholten J, et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res. 2008;17(2):307-315.
Li M, et al. Skin abnormalities generated by temporally controlled RXRa mutations in mouse epidermis. Nature. 2000;407(6804):633-636.
Benedetti F, et al. Sulfur compounds block MCP-1 production by Mycoplasma fermentans-infected macrophages through NF-KB inhibition. J Transl Med. 2014;12:145.
Dudeck A, et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity. 2011;34(6):973-984.
Gaudenzio N, Laurent C, Valitutti S, Espinosa E. Human mast cells drive memory CD4+ T cells toward an inflammatory IL-2 2+ phenotype. J Allergy Clin Immunol. 2013;131(5):1400-7.e11.
He R, Oyoshi MK, Wang JY, Hodge MR, Jin H, Geha RS. The prostaglandin D2 receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge. J Allergy Clin Immunol. 2010;126(4):784-790.
Caulín C, Scholl FG, Frontelo P, Gamallo C, Quinta-nilla M. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-p1 induces an epithelial-mesenchymal trans-differentiation and a spindle tumoral phenotype. Cell Growth Differ. 1995;6(8):1027-1035.
Gentleman RC, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80.
Marichal T, et al. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity. 2013;39(5):963-975.